Chemed Corporation CHE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 690.94M | 673.25M | 657.51M | 639.34M | 624.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 690.94M | 673.25M | 657.51M | 639.34M | 624.90M |
| Cost of Revenue | 457.98M | 451.78M | 441.75M | 414.17M | 425.14M |
| Gross Profit | 232.96M | 221.47M | 215.76M | 225.17M | 199.76M |
| SG&A Expenses | 111.47M | 115.20M | 114.32M | 102.80M | 105.78M |
| Depreciation & Amortization | 17.40M | 16.99M | 16.87M | 16.33M | 16.23M |
| Other Operating Expenses | -- | 78.00K | -8.00K | -225.00K | -- |
| Total Operating Expenses | 586.85M | 584.05M | 572.94M | 533.07M | 547.15M |
| Operating Income | 104.09M | 89.20M | 84.58M | 106.26M | 77.75M |
| Income Before Tax | 96.71M | 91.33M | 88.84M | 105.45M | 83.54M |
| Income Tax Expenses | 25.06M | 23.63M | 22.54M | 28.69M | 19.31M |
| Earnings from Continuing Operations | 71.65M | 67.70M | 66.30M | 76.75M | 64.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.65M | 67.70M | 66.30M | 76.75M | 64.24M |
| EBIT | 104.09M | 89.20M | 84.58M | 106.26M | 77.75M |
| EBITDA | 121.49M | 106.19M | 101.45M | 118.29M | 93.98M |
| EPS Basic | 5.49 | 5.14 | 4.85 | 5.48 | 4.46 |
| Normalized Basic EPS | 5.00 | 4.33 | 4.06 | 4.96 | 3.76 |
| EPS Diluted | 5.45 | 5.13 | 4.84 | 5.48 | 4.46 |
| Normalized Diluted EPS | 4.97 | 4.32 | 4.06 | 4.95 | 3.75 |
| Average Basic Shares Outstanding | 13.06M | 13.17M | 13.68M | 13.99M | 14.39M |
| Average Diluted Shares Outstanding | 13.14M | 13.20M | 13.69M | 14.01M | 14.41M |
| Dividend Per Share | 0.70 | 0.60 | 0.60 | 0.60 | 0.60 |
| Payout Ratio | 12.82% | 11.63% | 12.33% | 11.07% | 13.47% |